Altrincham, United Kingdom

Hans Ake Eriksson

USPTO Granted Patents = 2 

Average Co-Inventor Count = 11.5

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Hans Ake Eriksson

Introduction

Hans Ake Eriksson is a notable inventor based in Altrincham, GB. He has made significant contributions to the field of medicine, particularly in the treatment of various disorders using psilocybin. With a total of two patents to his name, Eriksson's work is paving the way for innovative therapeutic methods.

Latest Patents

Eriksson's latest patents focus on groundbreaking methods for treating anxiety disorders, headache disorders, and eating disorders with psilocybin. The disclosure provides methods for treating a subject in need thereof, comprising administering a therapeutically-effective dose of psilocybin. These methods may be utilized to address a variety of diseases, disorders, and conditions. Additionally, he has developed methods for treating neurocognitive disorders, chronic pain, and reducing inflammation. This patent also involves administering psilocybin to treat conditions such as Alzheimer's disease, Parkinson's disease, ADHD, epilepsy, autism, sleep-wake disorders, chronic pain, inflammatory disorders, IBD, stroke, ALS, and multiple sclerosis.

Career Highlights

Eriksson is currently associated with Compass Pathfinder Limited, where he continues to innovate and develop new therapeutic methods. His work is characterized by a commitment to improving the quality of life for individuals suffering from various mental and physical health issues.

Collaborations

Some of Eriksson's notable coworkers include Derek John Londesbrough and Christopher Brown. Their collaborative efforts contribute to the advancement of research and development in the field of psilocybin treatments.

Conclusion

Hans Ake Eriksson is a pioneering inventor whose work in psilocybin-based therapies is making a significant impact in the medical field. His innovative approaches to treating complex disorders highlight the potential of psilocybin as a therapeutic agent.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…